I will keep the write-up short. Buying Misys (MSY LN) and shorting Allscripts (MDRX) will create a stub free on equity basis, for two profitable software divisions and at 2x EV/EBITDA and 0.9x EV/maintenance sales. You also have ValueAct who owns 25% of MSY, which should protect/unlock the value for shareholders.
Background: Misys is a UK software firm that had two divisions, finance (Banking, Treasury & Capital Markets), and healthcare. In Oct ’08, the company merged its healthcare division with US Based Allscripts and owns 54.5% of the new company.
Numbers: (MSY intraday, MDRX based on closing price on Friday).
MDRX
$9.49
Shares
152
MDRX Market Cap
$1,442
USD/GBP Exchange Rate
1.4832
MDRX Market Cap in GBP
£973
Misys Shares
£549
Misys stock price
£98
Misys Market Cap
£533
Misys ownership of MDRX
54.5%
Misys's MDRX Holding
£530
54.5% holding
Core banking / TCM
£3
Net Debt
£120
EV
£123
TTM
CY09
CY10
TCM+CB EBITA
54.5
60.5
66.7
Central Cost
-10
-10.0
-10.0
Interest
-10
-10.0
-10.0
PBT
34.5
40.5
46.7
Tax (@ 30%)
-10.4
-12.2
-14.0
Net Income
24.2
28.4
32.7
P/E
0.1
0.1
0.1
EV/EBITDA
2.3
2.0
1.8
Maint Sales
138.3
141.0
144.6
NI on Maint Stream
12.5
14.4
P/E (Maint Stream)
0.2
0.2
EV/Maint Sales
0.9
0.9
0.9
Why the opportunity: After the deal had closed, MDRX went up 90% while MSY went down 15%. It is not clear to me what drove this divergence. I can only speculate that 1) investors may have high hope for MDRX under a new democrat regime under Obama, 2) Russell 2000 index increased MDRX’s weighting. 3) investors were skeptical of the TCM/CB division with all the trouble circling the financials industry. I think 1) and 2) are largely short-term issues that are largely irrelevant once you create the stub. As for 3), I would note current valuation is already discounting an Armageddon case. 44% of the revenue of the TCM/CB division is maintenance revenue. For the last 5 fiscal years, the division had sales of 240M, 245M, 267M, 273M, 301M, and EBITA of 38M, 41M, 38M, 48M, 51M respectively. I will leave the readers to decide how much of a discount multiple Misys's legacy division should get (there are plenty of sell-side reports discussing the impact). Curiously, MYS has 4 buys, 9 holds, 5 sells, while MDRX has 7 buys, 11 Holds and no sells.
Catalyst
1) Both stocks are pretty liquid, so the valuation gap should eventually close.
2) ValueAct may force some additional corporate action.
Are you sure you want to close this position Misys PLC?
By closing position, I’m notifying VIC Members that at today’s market price, I no longer am recommending this position.
Flag Misys PLC for Removal
Are you sure you want to Flag this idea Misys PLC for removal?
Flagging an idea indicates that the idea does not meet the standards of the club and you believe it should be removed from the site. Once a threshold has been reached the idea will be removed.
You Cannot Submit Message ... Yet
You currently do not have message posting privilages, there are
1 way you can get the privilage.
You can apply for full membership by submitting an investment idea of your own. Or if you are in reactivation status, you need to reactivate your full membership.